Iatrogenic Hypoglycemia in Type 2 Diabetes Affects Endothelial Proteins Involved in Cardiovascular Dysfunction

Area of Science:

• Cardiovascular Science
• Endocrinology
• Proteomics

Background:

• Hypoglycemia is linked to cardiovascular events and platelet abnormalities.
• Endothelial dysfunction is a key factor in diabetic vasculopathy.
• Sequential changes in endothelial proteins during hypoglycemia may increase cardiovascular risk.

Purpose of the Study:

• To investigate sequential endothelial protein changes during and after hypoglycemia in type 2 diabetes (T2D) patients and controls.
• To determine if hypoglycemia exacerbates endothelial dysfunction and cardiovascular risk in T2D.

Main Methods:

• Prospective parallel study design with 23 T2D patients and 23 controls.
• Blood SOMAscan proteomic analysis of endothelial proteins at baseline, during, and up to 24h post-hypoglycemia.
• Repeated-measures linear mixed modeling to analyze protein level changes.

Main Results:

• Baseline differences in endothelial proteins (e.g., higher P-selectin, PAI-1; lower cadherin-5) were observed in T2D patients.
• Hypoglycemia induced changes in endothelial proteins (e.g., decreased cadherin-5, increased P-selectin, PAI-1) in both groups.
• Post-hypoglycemia, specific endothelial proteins remained altered, with some showing group differences (e.g., lower E-selectin, P-selectin, ICAM3 in T2D).

Conclusions:

• Baseline endothelial protein profiles differ between T2D patients and controls, suggesting pre-existing endothelial inflammation and a pro-thrombotic state.
• Hypoglycemia may exacerbate endothelial dysfunction, promoting a pro-adhesive and pro-thrombotic phenotype, thereby increasing cardiovascular risk in T2D.